Talking about tobacco harm reduction means embracing a plurality of behaviors, choices and products that can be confusing. We have deepened the subject with Dr. Renée O’Leary, author of the paper and COEHAR researcher
Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Unfortunately, socio-cultural and economics barriers, such as heavy taxation, misperceptions about nicotine and unsubstantiated fears of youth addiction, prevent low risk products to become accessible to all and a good choice for those who want to quit smoking.
The findings from a survey conducted by COEHAR researchers on almost 2000 participants showed a slight decrease in the consumption of cigarettes during the lockdown period and an increase in the purchase of products such as cigarettes and e-liquid
A recent study by Prof. Brake SJ studied the correlation between smoking and the angiotensin converting enzyme 2 and its implications to COVID-19. The author's hypothesis suggests an increased risk…
Prof. Riccardo Polosa talks about the Italian Government decision to close all the non-essential shops in Italy, vapeshops included
We have talked to DR. Colin Mendelsohn about the new Australian smoking cessation guidelines which now suggest the use of ECIG
Leggi anche la versione italiana By Derek Yach, president of Foundation for a Smoke Free World The Strait of Messina between Sicily and Calabria, Italy, has seen ancient civilizations come…
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.